IMPACT OF ATRIAL FIBRILLATION ON PLATELET-PREDOMINATE GENE EXPRESSION  by Wysokinski, Waldemar E. et al.
E1518
JACC April 5, 2011
Volume 57, Issue 15
  VASCULAR DISEASE
IMPACT OF ATRIAL FIBRILLATION ON PLATELET-PREDOMINATE GENE EXPRESSION
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 9:30 a.m.-10:45 a.m.
Session Title: Angiogenesis and Cytokines
Abstract Category: 9. Vascular—Pathophysiology—Basic/Angiogenesis/Gene Therapy
Session-Poster Board Number: 1076-110
Authors: Waldemar E. Wysokinski, Alfonso Tafur, Thomas G. McLeod, Naser Ammash, Win-Kuang Shen, Diane D. Grill, Jessica Sonbert, Shelly L. 
Whelan, Jozef Mruk, Robert D. McBane, II, Mayo Clinic, Rochester, MN
Background: Platelets retain cytoplasmic mRNA and are capable of protein biosynthesis upon stimulation. Platelet release from bone marrow 
megakaryocytes is a flow mediated process. Changes in hemodynamics, as is seen in non-valvular atrial fibrillation (NVAF) may impact platelet RNA 
and protein biosynthesis.
Methods: To address the hypothesis that hemodynamic changes of cardiac rhythm impact the platelet transcriptome, 22 platelet-predominate 
genes expression was assessed before and 3 months after sinus rhythm (NSR) restoration by radiofrequency ablation. RNA from isolated platelets 
were reverse-transcribed (Invitrogen), assayed against 24 genes (TaqMan) using real-time qPCR, and expressed as mean cycle threshold (Ct) using 
beta-2-microglobulin and ubiquitin C asendogenous controls. 
Results: 66 patients with NVAF (age 59±9.8; 32% women; 68% with paroxysmal AF) underwent successful ablation therapy. With re-establishing 
sinus rhythm, a significant change in gene expression was noted in 9 genes (Table). Of these, changes in insulin-like growth factor binding protein 
gene expression, a key regulator of platelet activity, was the most remarkable.
Conclusions: NVAF induced changes in platelet related gene expression may contribute to the thrombotic propensity of this dysrhythmia. Changes 
in insulin-like growth factor binding protein gene expression may provide insight to risk of thrombosis in NVAF patients with diabetes. 
Gene (symbol)
Gene Expression
(Mean Delta CT)* P
Before RFA After RFA
Insulin-like growth factor binding protein (IGFALS) 16.62 8.29 0.0000054
Cofilin 1 -non-muscle (CFL1) 7.737 6.348 0.000318
Platelet factor 4 (PF4) 2.83 1.588 0.000511
Glycoprotein Ib (GP1BB) 5.774 4.411 0.005248
GRB2-related adaptor protein (GRAP2) 4.155 4.678 0.008167
Integrin _2bß3 (ITGA2B) 6.403 6.901 0.013401
Progesterone receptor component (PGRMC1) 6.091 5.655 0.014649
DD96 membrane associated protein (PDZK1IP) 6.968 6.195 0.024178
Cathepsin A (CTSA) 4.31 4.676 0.044985
*Note, the lower Ct value the higher target gene expression.
